| Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 16732 | 2014 |
| 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European … Authors/Task Force Members, SV Konstantinides, A Torbicki, G Agnelli, ... European heart journal 35 (43), 3033-3080, 2014 | 4435 | 2014 |
| COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ... Journal of the American college of cardiology 75 (23), 2950-2973, 2020 | 3380 | 2020 |
| Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice … JD Douketis, AC Spyropoulos, FA Spencer, M Mayr, AK Jaffer, ... Chest 141 (2), e326S-e350S, 2012 | 2014 | 2012 |
| Perioperative bridging anticoagulation in patients with atrial fibrillation JD Douketis, AC Spyropoulos, S Kaatz, RC Becker, JA Caprini, AS Dunn, ... New England Journal of Medicine 373 (9), 823-833, 2015 | 1277 | 2015 |
| The perioperative management of antithrombotic therapy: American College of Chest Physicians evidence-based clinical practice guidelines JD Douketis, PB Berger, AS Dunn, AK Jaffer, AC Spyropoulos, RC Becker, ... Chest 133 (6), 299S-339S, 2008 | 1180 | 2008 |
| Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients … S Kaatz, D Ahmad, AC Spyropoulos, S Schulman Journal of Thrombosis and Haemostasis 13 (11), 2119-2126, 2015 | 871 | 2015 |
| Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with … AC Spyropoulos, JH Levy, W Ageno, JM Connors, BJ Hunt, T Iba, M Levi, ... Journal of Thrombosis and Haemostasis 18 (8), 1859-1865, 2020 | 777 | 2020 |
| Rivaroxaban for thromboprophylaxis in acutely ill medical patients AT Cohen, TE Spiro, HR Büller, L Haskell, D Hu, R Hull, A Mebazaa, ... New England Journal of Medicine 368 (6), 513-523, 2013 | 736 | 2013 |
| Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism VF Tapson, H Decousus, M Pini, BH Chong, JB Froehlich, M Monreal, ... Chest 132 (3), 936-945, 2007 | 628 | 2007 |
| Predictive and associative models to identify hospitalized medical patients at risk for VTE AC Spyropoulos, FA Anderson Jr, G FitzGerald, H Decousus, M Pini, ... Chest 140 (3), 706-714, 2011 | 577 | 2011 |
| Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates D Siegal, J Yudin, S Kaatz, JD Douketis, W Lim, AC Spyropoulos Circulation 126 (13), 1630-1639, 2012 | 543 | 2012 |
| Subcommittee on Control of Anticoagulation. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic … S Kaatz, D Ahmad, AC Spyropoulos, S Schulman J Thromb Haemost 13 (11), 2119-2126, 2015 | 509 | 2015 |
| How I treat anticoagulated patients undergoing an elective procedure or surgery AC Spyropoulos, JD Douketis Blood, The Journal of the American Society of Hematology 120 (15), 2954-2962, 2012 | 479 | 2012 |
| Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators H Decousus, VF Tapson, JF Bergmann, BH Chong, JB Froehlich, ... Chest 139 (1), 69-79, 2011 | 479 | 2011 |
| Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19 … AC Spyropoulos, M Goldin, D Giannis, W Diab, J Wang, S Khanijo, ... JAMA internal medicine 181 (12), 1612-1620, 2021 | 425 | 2021 |
| Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and thrombotic or … B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ... J Am Coll Cardiol 75 (23), 2950-2973, 2020 | 405 | 2020 |
| Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations AC Spyropoulos, J Lin Journal of Managed Care Pharmacy 13 (6), 475-486, 2007 | 394 | 2007 |
| Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant JD Douketis, AC Spyropoulos, J Duncan, M Carrier, G Le Gal, AJ Tafur, ... JAMA internal medicine 179 (11), 1469-1478, 2019 | 378 | 2019 |
| Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients AT Cohen, R Alikhan, JI Arcelus, JF Bergmann, S Haas, GJ Merli, ... Thrombosis and haemostasis 94 (10), 750-759, 2005 | 342 | 2005 |
